PATENT CLAIM ANALYSIS

Application Number: 16069313
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "013200"]

Abstract:
This invention provides composition and methods to prevent, treat or alleviate a symptom of ulcerative colitis comprising administering to a patient dolcanatide.

Claim (Index 2):
The method of  claim 1 , wherein the effective amount is between about 1 mg to 10 mg per dose.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14207749', '15272873', '14301812', '15049740', '14189645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7376994849533224
- 35 USC 102 Novelty (BERT): 0.5017477639863005
- Combined Prediction Score: 0.7141043128566202
- Mean Citation Score: 283.946714
- Max Citation Score: 287.0988200000001
- Similarity Product: 285.5624324219156

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test